Around the Practice May 19, 2021: Adverse Event Management in Genitourinary Cancers

EP1: AEs from Novel Hormone Therapy in Nonmetastatic Castrate Resistant Prostate Cancer

May 26th 2021

In Urology Times’ monthly installment of Around the Practice, experts discuss adverse event management from various treatments for prostate and bladder cancer.

EP2: AEs from PARP Inhibitors in Metastatic Castrate Resistant Prostate Cancer

May 26th 2021

In Urology Times’ monthly installment of Around the Practice, experts discuss adverse event management from various treatments for prostate and bladder cancer.

EP3: AEs from Immunotherapy monotherapy for BCG-Unresponsive NMIBC

May 26th 2021

In Urology Times’ monthly installment of Around the Practice, experts discuss adverse event management from various treatments for prostate and bladder cancer.